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Abstract: There was a significant male excess in the newborns of pregnant women with severe 
chronic constipation during pregnancy compared to pregnant women without constipation and 
pregnant women with new onset severe constipation, during pregnancy.
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Constipation affects between 11% and 38% of pregnant women;1 the aim in our previous 
study was to estimate the association between pregnant women with constipation and 
congenital abnormalities in their offspring2 in the Hungarian Case-Control   Surveillance 
of Congenital Abnormalities (HCCSCA), 1980–1996.3 Here, an unexpected secondary 
finding of the study is reported.
The HCCSCA is based on the comparison of cases with different congenital 
  abnormalities and matched controls (ie, newborns without any defect). Cases are 
selected from the Hungarian Congenital Abnormality Registry while controls are 
  collected from the National Birth Registry of the Central Statistical Office. In gen-
eral two controls are matched to each case according to sex, date of birth, and area 
of   residence of mothers. Here only the data of controls are shown because   congenital 
abnormalities may have a more drastic effect for birth outcomes than maternal 
  constipation. Prenatal care was mandatory for pregnant women in Hungary, the average 
number of their visits was seven during the study pregnancy and obstetricians recorded 
all maternal diseases and related drug treatments in a prenatal maternity logbook. In 
addition mothers were asked to fill in a structured questionnaire regarding their diseases 
and related drug treatments during the study pregnancy after their deliveries. The birth 
outcomes of newborns were recorded in the discharge summaries (in Hungary almost 
all deliveries occurred in inpatient obstetric clinics).
Statistical analyses were carried out using SAS version 8.02 (SAS Institute Ins., 
Cary, NC). The categorical variables of mothers with and without severe constipation 
as reference group and their newborns were compared by chi-square test and odds 
ratio (OR) with 95% confidence intervals (CI) in ordinary logistic regression model, 
while the Student’s t-test was used to analyze quantitative variables.
The preliminary analysis of pregnant women with constipation showed two 
  different categories: (1) Severe constipation was recorded in the prenatal maternity 
logbooks and these pregnant women were treated with drugs (generally by senna, 
rarely by phenolphthalein); and (2) Mild constipation was reported retrospectively in 
the questionnaire by mothers, and in general these pregnant women were not treated Clinical Epidemiology 2010:2 submit your manuscript | www.dovepress.com
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with laxative drugs. The maternal sensitivity and reporting 
attitude was different, particularly regarding nonsevere 
pathological symptoms.3 Thus we decided to evaluate only 
pregnant women with severe constipation in the study. Of 
38,151 controls, 144 mothers had severe constipation and 
these women were older than controls (mean age ± standard 
deviation (SD): 26.6 ± 4.9 versus 25.4 ± 4.9 years) with a 
higher proportion of professional and managerial employ-
ment (50.0% versus 37.9%), and with more frequent use of 
folic acid during the study   (64.6% versus 54.4%) compared 
to 38,007 pregnant women without severe constipation.
The birth outcomes of newborns were also compared 
in the groups of pregnant women with or without severe 
  constipations: a longer mean gestational period (39.8 ± 1.9 
versus 39.4 ± 2.2 weeks, P = 0.03) and lower rate of 
  preterm birth (4.2% versus 9.2%, OR with 95% CI: 0.46, 
0.21–0.96) were found in the newborns of women with severe 
  constipation. However, the mean birth weight (3,275 ± 516 
versus 3,276 ± 511 g, P = 0.11) and the rate of low birth 
weight (4.2% versus 5.7%, OR with 95% CI: 1.14, 0.43–2.93) 
did not show significant difference in these two groups of 
newborns. The lower rate of preterm birth can be explained 
by the more frequent use of folic acid by the mothers with 
severe constipation.4
The major unexpected finding was an obvious male excess 
in the newborns of pregnant women with severe constipation 
(Figure 1). At first sight the male excess in the newborns 
of reference pregnant women without   medically recorded 
constipation is disturbing. The explanation is that controls 
in the HCCSCA were matched to the cases   according to sex 
and cases with congenital abnormalities have an   obvious 
male excess (65%:35%) in the HCCSCA. This well-know 
male excess among malformed cases is explained by some 
X-linked defects (eg, some part of cleft palate), by certain 
congenital abnormalities such as congenital pyloric stenosis, 
and mainly by a much higher incidence of defects in male 
genital organs (hypospadias and undescended testis) than in 
female genital organs.
In the next step two types of severe constipation were 
differentiated (Figure 1): chronic (the onset was before 
  conception which continued during pregnancy) and   new-  onset 
(after the third gestational months). The male excess was 
significantly higher only in the newborns of pregnant women 
with severe chronic constipation (χ2
1 = 5.9, P = 0.01).
Theoretically there are four explanations for this unex-
pected finding: (i) A higher rate of miscarriages (ie, early 
  postconceptional selection) of female embryos.   Unfortunately 
the HCCSCA is not appropriate for the evaluation of 
Total number of newborns 
38,151
Without severe constipation (as reference) With severe constipation 
No.:
No.:
38,007
24,393:13,614
New onset Chronic
1.5 (1.1 – 2.2)*
84
56 28 48 12
66.7%:33.3% 80.0%:20.0%
1.1 (0.6 – 1.9)* 2.2 (1.1 – 4.1)
60
OR (95% Cl)
OR (95% Cl)
Constipation
64.2%:35.8% 73.6%:23.4%
Sex (male:female) ratio
Sex (male:female) ratio
144
106:38
Figure 1 Data set of control newborns in the HCCsCA, 1980–1996. 
Notes: *Adjusted for maternal age and employment, in birth order.
Abbreviations: HCCsCA, Hungarian Case-Control Surveillance of Longenital Abnormalities; CL, confidence intervals; OR, odds ratio.Clinical Epidemiology
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miscarriages in the study pregnancy. However, the rate of 
  miscarriages is known in the previous pregnancies of these 
women, and it was not higher, though we could assume that the 
chronic constipation existed in their previous   pregnancies as 
well; (ii) The sex of conceptions is determined mainly by the 
sex chromosome of spermatozoa, ie, males. Pregnant women 
are in the focus of the HCCSCA, although assessments of the 
major diseases in the fathers of cases and   controls are included 
in the questionnaire. There was no cluster of   specific diseases 
in the male partners of pregnant women with severe chronic 
constipation; (iii) Chronic severe constipation may modify the 
pH of vaginal fluid and the less acidic vaginal pH may favor 
the transfer of spermatozoa including Y chromosome;5 (iv) 
Results could be due to chance or   unevaluated confounders.
In conclusion, severe chronic constipation of pregnant 
women was found to be associated with a higher proportion 
of males among newborns. This finding is not important 
from a clinical perspective, but theoretically is an interesting 
phenomenon therefore further studies are required.
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